Kotak Healthcare Fund holds 37 instruments (98.69% equity), led by Sun Pharmaceutical Industries Limited (13.21%), Divi's Laboratories Limited (9.35%) and MOLBIO DIAGNOSTICS LTD (5.08%), as of its 30 September 2026 SEBI-mandated monthly disclosure.
This page shows the complete disclosed portfolio of Kotak Healthcare Fund, managed by Kotak Mahindra Mutual Fund, based on its monthly portfolio disclosure dated 30 September 2026. The fund holds 37 instruments with an equity allocation of 98.69%. Percentages are of net assets (% to NAV). Click any stock to see every other mutual fund that also holds it.
Kotak Healthcare Fund's top 10 holdings account for 52.78% of its portfolio, more concentrated than the Thematic category average of 49.2%. Healthcare is its largest sector exposure at 93.39% of net assets, spread across 2 sectors in total. Since its 31 August 2026 disclosure, the fund added 1 new position and exited 1 position, with Sun Pharmaceutical Industries Limited seeing the largest move (-0.75pp to 13.21%).
Equity holdings grouped by sector, % to NAV. "Other" covers debt, cash and other non-equity instruments, plus any equity holding without a classified sector.
Equity holdings compared between the fund's two latest monthly disclosures. Weights are % to NAV; weight moves can also reflect price changes, not only buying or selling.
| Stock | Weight | Change |
|---|---|---|
| MOLBIO DIAGNOSTICS LTD | 4.53% → 5.08% | ▲ +0.55 |
| Laurus Labs Limited | 2.49% → 2.88% | ▲ +0.39 |
| Innova Captab Limited | 1.08% → 1.41% | ▲ +0.33 |
| Acutaas Chemicals Limited | 3.91% → 4.17% | ▲ +0.26 |
| Krishna Institute of Medical Sciences Limited | 2.46% → 2.71% | ▲ +0.25 |
| Emcure Pharmaceuticals Limited | 1.57% → 1.77% | ▲ +0.2 |
| Aurobindo Pharma Limited | 1.57% → 1.72% | ▲ +0.15 |
| Gland Pharma Limited | 3.04% → 3.16% | ▲ +0.12 |
| Jubilant Pharmova Limited | 1.15% → 1.25% | ▲ +0.1 |
| Divi's Laboratories Limited | 9.25% → 9.35% | ▲ +0.1 |
| Stock | Weight | Change |
|---|---|---|
| Sun Pharmaceutical Industries Limited | 13.96% → 13.21% | ▼ -0.75 |
| Max Healthcare Institute Limited | 4.34% → 3.61% | ▼ -0.73 |
| Fortis Healthcare Limited | 2.95% → 2.33% | ▼ -0.62 |
| Rubicon Research Limited | 2.37% → 1.96% | ▼ -0.41 |
| Cipla Limited | 3.67% → 3.26% | ▼ -0.41 |
| Viyash Scientific Limited | 2.01% → 1.71% | ▼ -0.3 |
| Apollo Hospitals Enterprise Limited | 3.25% → 2.97% | ▼ -0.28 |
| Pfizer Limited | 1.16% → 0.89% | ▼ -0.27 |
| Park Medi World Limited | 3.36% → 3.17% | ▼ -0.19 |
| Rainbow Childrens Medicare Limited | 1.29% → 1.11% | ▼ -0.18 |
% to NAV of the fund's current top holdings over its last 6 monthly disclosures (Apr – Sept 2026).
New to reading these? See How to Read a Mutual Fund's Monthly Portfolio Disclosure, or check terms like % to NAV in the glossary.
Source: Kotak Mahindra Mutual Fund's SEBI-mandated monthly portfolio disclosure, dated 30 September 2026. Data is for information only, not investment advice. Holdings may have changed since the disclosure date.